SCHAUMBURG, Ill.--(BUSINESS WIRE)--APP Pharmaceuticals, Inc. (Nasdaq:APPX) today announced the launch of enhanced labeling for its line of Heparin Sodium Injection, USP. The labels and cap colors for ...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S.

One of the most important App Store metrics for publishers and developers is the average price of the games making up the Top 100. Over the past month, it's hovered around the $2.70 mark, with roughly ...

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ:APCVZ), announced today that it has received approval from the U.S. Food and Drug ...

NEW YORK (MarketWatch) -- APP Pharmaceuticals Inc. on Thursday said the U.S. Food and Drug Administration OK'd its Abbreviated New Drug Application for Polymyxin B Sulfate for Injectionpolymyxin B ...

FDA okays oxaliplatin for injection in 50 mg and 100 mg Fresenius Kabi shares up 27 pct in pre-market trade June 8 (Reuters) - APP Pharmaceuticals Inc, a unit of Fresenius Kabi Pharmaceuticals Holding ...